Down Syndrome - a genetic disorder - is incurable. However, stem cell experts have reached a conclusion that stem cell treatment can lead to some improvement giving better life even if no permanent cure can be promised.
A three-year-old baby - born with Down Syndrome having subnormal motor skills - has shown improvement after undergoing stem cell treatment at a hospital in New Delhi, doctors said.
Down Syndrome
Down Syndrome is a congenital disorder among children commonly born to older mothers. The condition is also known as 'Up syndrome' because of the cheerful persona of the Down children.
Advertisement
‘A three-year-old baby - born with Down Syndrome having subnormal motor skills - has shown improvement after undergoing stem cell treatment.’
Tweet it Now
Rahul (name changed) was born preterm due to premature rupture of membranes (PROM) and was kept in intensive care unit (ICU) for two days due to respiratory distress.
Following diagnosis of Down Syndrome and subnormal motor skills, the patient was shown to a city-based stem cell expert.
The baby was admitted with complaints of delayed milestones, lack of voice, cardiac defects, slanted eyes and with no neck holding capacity.
![New Test To Diagnose Speech and Motor Defects in Down Syndrome]( "New Test To Diagnose Speech and Motor Defects in Down Syndrome")
Inability to perform particular purposive actions and unclear articulation of speech are misdiagnosed in children with Down Syndrome.
According to the doctor, the patient underwent two sessions of stem cell therapy of which the first session lasted approximately three months.
"By the end of three months, the muscle tone was better in all limbs. He (patient) had started babbling and crawling. He was social and was able to recognize his near ones after the first session. Better outcomes were observed with no adverse events," said Geeta Shroff, stem cell expert with city-based Nutech Mediworld.
According to Shroff, the results and improvements have shown that the new medical technology has the potential to replace damaged neurons, re-establish lost axonal connections, and provide treatment for various neural and congenital disorders.
"Embryonic stem cell lines used during the treatment have been derived from a single spare fertilized egg that donated during a IVF cycle. This fertilized egg would have otherwise been medical waste," Shroff said.
About 50% of all babies born with Down syndrome are also born with a congenital heart defect.
Source: IANS
The baby was admitted with complaints of delayed milestones, lack of voice, cardiac defects, slanted eyes and with no neck holding capacity.
New Test To Diagnose Speech and Motor Defects in Down Syndrome
Inability to perform particular purposive actions and unclear articulation of speech are misdiagnosed in children with Down Syndrome.
Advertisement
According to the doctor, the patient underwent two sessions of stem cell therapy of which the first session lasted approximately three months.
"By the end of three months, the muscle tone was better in all limbs. He (patient) had started babbling and crawling. He was social and was able to recognize his near ones after the first session. Better outcomes were observed with no adverse events," said Geeta Shroff, stem cell expert with city-based Nutech Mediworld.
According to Shroff, the results and improvements have shown that the new medical technology has the potential to replace damaged neurons, re-establish lost axonal connections, and provide treatment for various neural and congenital disorders.
"Embryonic stem cell lines used during the treatment have been derived from a single spare fertilized egg that donated during a IVF cycle. This fertilized egg would have otherwise been medical waste," Shroff said.
About 50% of all babies born with Down syndrome are also born with a congenital heart defect.
Source: IANS
Statistics of Down Syndrome Population in the US may be Overestimated
The new detailed estimation of Down syndrome may be useful for policymakers to better appraise the impact of proposed legislation for this population.
Advertisement
 Model With Down Syndrome for a Beauty CampaignBeauty & Pin-Ups hair mask called Fearless Hair Rescue Treatment features Katie the first woman with Down syndrome to campaign for a beauty product. | Advertisement
|
Advertisement
Recommended Reading
Latest Genetics & Stem Cells News
Scientists have developed the first humanized mouse model for a rare hereditary condition.
A recent study discovered that the placenta, rather than only the brain, is crucial in determining the genetic risk of schizophrenia.
FOXI3 gene was found to be involved in Goldenhar syndrome, one form of developmental disorder, revealed research.
Contrary to previous beliefs, genes may not be fixed and can be influenced by environmental factors and lifestyle choices, according to modern scientific research.
Gene therapy successfully tested on dogs with inherited eye disease is now poised for clinical use in humans.